Foresight Technology VCT and EIS invests £0.8m into Lifelight

Company background

Xim Limited, ("Lifelight") is a UK-based early-stage medical software company developing contactless vital signs monitoring technology. Its core product, Lifelight, uses a smartphone or tablet camera to measure heart rate, blood pressure and respiration without any physical contact or clinical equipment. The app is available standalone or as a licensed software kit and independent clinical trials have shown its accuracy to be comparable or better than traditional blood pressure cuffs across all ranges and for users aged 14–60. Importantly, the technology has been trained across the full skin tone spectrum and a wide range of health conditions

Investment

Lifelight is generating revenue and moving toward profitability. During the period, further progress has been made towards entering the US market. The new investment, which completed in October 2025, will also help expand its sales and marketing team, accelerating international sales and strategic partnerships. Lifelight’s core product, a smartphone-based blood pressure measurement app, is already being adopted across multiple sectors, including healthcare providers, digital health and wellbeing platforms and insurance companies.

Strategy

Lifelight has partnered with NowPatient, a global telehealth platform, to integrate its technology into virtual care workflows, enabling remote prescribing. In June 2025, Lifelight became the first company globally to achieve EU Class II medical certification for blood pressure measurement using only a smartphone camera, eliminating the need for cuffs or wearables. The technology is now deployed across 1,700 UK primary care practices and is being piloted by National Health Service bodies, including Hampshire and the Isle of Wight Integrated Care Board, to support cardiovascular screening and chronic disease management.